Safety and efficacy of topical, fixed‐dose combination calcipotriene (0.005%) and betamethasone (0.064% as dipropionate) gel in adolescent patients with scalp and body psoriasis: a phase II trial
2020 ◽
Vol 34
(5)
◽
pp. 1098-1104
◽
Keyword(s):
Phase Ii
◽
2020 ◽
Vol 34
(9)
◽
pp. 2026-2034
◽
Keyword(s):
1995 ◽
Vol 13
(12)
◽
pp. 1847???1851
◽
Keyword(s):
2016 ◽
Vol 15
(4)
◽
pp. 549-557
◽
Keyword(s):
2010 ◽
Vol 32
(6)
◽
pp. 1033-1049
◽
Keyword(s):
1992 ◽
Vol 21
(2)
◽
pp. 85-91
◽
Keyword(s):